| Cutaneous reactions to propranolol (Inderal). | |
| | |
MedLine Citation:
|
PMID: 132088 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Six patients wit psoriasiform cutaneous eruptions that developed during long-term therapy with propranolol (Inderal) have been studied. The cutaneous changes closely resembled those seen during treatment with practolol (Eraldin). The duration of treatment before the rash was recognized averaged 10 months, which is about the same latency period as in patients with practolol-induced exanthemas. The exanthemas disappeared gradually within 1-5 weeks after treatment with propranolol had been stopped. In 4 of 5 patients the skin eruptions reappeared within 2-4 days after oral challenge with propranolol. In the fifth patient, who developed a rash after challenge with practolol and severe abdominal colics after challenge with oxprenolol, no further provocation tests with propranolol were attempted. Skin biopsies obtained from 3 patients showed a microscopical picture similar to that seen in practolol exanthemas. The pathogenetic mechanism responsible for these adverse cutaneous reactions is unknown. However, since the possibility exists, that these changes may be caused by blockade of the epidermal beta-receptors, it is recommended that all patients receiving beta-blocking drugs should be examined carefully for similar adverse reactions. Special attention should be drawn to the reversible skin changes, since during treatment with practolol these have often preceded serious complications from other organs. |
| | |
Authors:
|
H A Jensen; H I Mikkelsen; S Wadskov; J Sondergaard |
Related Documents
:
|
19309368 - Enhanced expression of the antimicrobial peptide ll-37 in lesional skin of adults with ... 2494248 - Clinical zinc deficiency during adequate enteral nutrition. 6524338 - Collagen fibres in otosclerosis and in osteogenesis imperfecta tarda. a light and elect... 16464228 - Dermatological manifestations in primary biliary cirrhosis patients: a case control study. 7963418 - Cyclosporin a increases the biochemical markers of bone remodeling in primary biliary c... 17692378 - Clinical features of chinese patients with behçet's disease. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta medica Scandinavica Volume: 199 ISSN: 0001-6101 ISO Abbreviation: Acta Med Scand Publication Date: 1976 |
Date Detail:
|
Created Date: 1976-08-02 Completed Date: 1976-08-02 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370330 Medline TA: Acta Med Scand Country: SWEDEN |
Other Details:
|
Languages: eng Pagination: 363-7 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angina Pectoris / drug therapy Arrhythmias, Cardiac / drug therapy Drug Eruptions* / pathology Female Humans Hypertension / drug therapy Male Middle Aged Propranolol / adverse effects*, therapeutic use Skin / pathology |
| Chemical | |
Reg. No./Substance:
|
525-66-6/Propranolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phosphorylation of purine and pyrimidine nucleosides by isolated rat liver mitochondria.
Next Document: Chronic myocardial disease. I. Clinical picture related to long-term prognosis.